Hypera (FRA:HM6A) Short Interest


FRA:HM6A Hypera SA FRA:HM6A
92 GF Score
Price €3.54
GF Value €5.23
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Hypera Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:HM6A vs ZTS, UTHR, VTRS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hypera's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hypera Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hypera's Short Interest distribution charts can be found below:

* The bar in red indicates where Hypera's Short Interest falls into.


FRA:HM6A
92GF Score
Hypera SA FRA:HM6A
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hypera (FRA:HM6A) Overvalued in 2026?

Based on GuruFocus' analysis, Hypera stock appears to be undervalued. The current stock price of €3.54 is trading 32.3% below its estimated GF Value™ of €5.23. GuruFocus considers Hypera to be Possible Value Trap.

Key valuation signals for FRA:HM6A:

  • Short Interest:
  • GF Value™: €5.23 vs. price of €3.54 (32.3% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the FRA:HM6A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hypera Business Description

Address Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120
Hypera SA is a specialty and generic drug manufacturing company. The company operates in the prescription medicines, over-the-counter (OTC) medicines, branded generics, and generics, and skincare segments within the retail pharmaceutical market. The company also has a wide sales and distribution structure. The company's product portfolio includes key brands in Gastroenterology, Pain, Sun Protection, Skin Moisture, and Cleansing within the over-the-counter (OTC) and Skincare segments, as well as new products in Cardiology, Central Nervous System, and Respiratory System within the prescription medicines segment.
92GF Score

Get the complete analysis for FRA:HM6A

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.54
Price
€5.23
GF Value